MSK KINESIS Devices offer cutting edge technology for medical and wellness treatments that have been proven effective in France and Italy for over 14 years. Working exclusively with a founding MD in Italy, we have developed the technology and methods to improve a wide array of patients physical medical needs. MSK KINESIS Therapy makes it possible to treat, for the first time, the body’s myofascial “Band”. This is revolutionary because the Band not only holds together the organs and bowels, but is a sophisticated semiconductor system for high intensity piezoelectric energy contained in protein and collagen. Every bone, muscle, nerve or lymphatic blood vessel is surrounded by a layer of connecting fabric, which is tasked to support and protect these elements. In the past, it was anatomically considered as an inactive tissue, with limited functions. Today, the new biomechanics insight considers the Band as a fundamental part of the connection tissues action, effecting our muscles, strength, postural, motor and emotional behavioral wellness. The Bands integrity and elasticity allows the body to maintain a fluid integration between a biomechanic request for constant postural adaptation. The tension limits the capacity of movement and muscle overload resulting in an energy expenditure. Movement does not become metabolic activation of being, but rather a physical suffering with limitations that reflect on one’s mood, ultimately effecting restlessness, low capacity reactiveness and anxiety.
SALES, ASSISTANCE & TRAINING
USA & CANADA
HMNU on April 15, 2020 signed a binding preliminary contract with Life Scence s.r.l. for the acquisition of the exclusive commercial rights for Usa, Canada and South America of an innovative and efficace natural supplement based of astanxantine for the treatment of respiratory problems and inflammatory problems caused by infections and incontroled virus. www.life-science.it
Immune health has never been more topical. Astaxanthin from Haematococcus pluvialis microalgae has demonstrated wide-ranging effects on immune system modulation.
The Potential Role of Astaxanthin:
In pre-clinical and clinical studies, astaxanthin has demonstrated the ability to decrease levels of pro-inflammatory cytokines (IL-1, IL-6, TNF-α, and CRP) in multiple models of disease and in several patient populations. Astaxanthin has also demonstrated exceptional safety in multiple animal models, has been used extensively in humans for two decades as a dietary supplement, and is GRAS (Generally Recognized as Safe), according to FDA regulations.